Clinical trial
A Randomized Perspective, Open and Parallel Controlled Study Comparing 3M Tegaderm CHG I.V. Securement Dressing With 3M Tegaderm Transparent Dressing for Evaluation of Antimicrobial Efficacy on DVC Insertion Site in Adult in Critical Care
NCT04906512 is registered in ClinicalTrials.gov with Solventum US LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Perspective, Open and Parallel Controlled Study Comparing 3M Tegaderm CHG I.V. Securement Dressing With 3M Tegaderm Transparent Dressing for Evaluation of Antimicrobial Efficacy on DVC Insertion Site in Adult in Critical Care
- Lead sponsor
- Solventum US LLC
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 14, 2021
- Completion date
- March 31, 2022
- Enrollment
- 123 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
catheter-related infections, central venous catheter exit site infection